Michael Kluge

1.6k total citations
34 papers, 1.0k citations indexed

About

Michael Kluge is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Michael Kluge has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Immunology and 8 papers in Oncology. Recurrent topics in Michael Kluge's work include interferon and immune responses (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Cell death mechanisms and regulation (4 papers). Michael Kluge is often cited by papers focused on interferon and immune responses (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Cell death mechanisms and regulation (4 papers). Michael Kluge collaborates with scholars based in Germany, United States and United Kingdom. Michael Kluge's co-authors include Caroline C. Friedel, Hongyan Zou, Roland H. Friedel, Bin Zhang, Marie-Sophie Friedl, Peter Vaupel, Lei Guo, Shalaka Wahane, Xiang Zhou and Xijing He and has published in prestigious journals such as Nature, Nucleic Acids Research and Nature Communications.

In The Last Decade

Michael Kluge

33 papers receiving 981 citations

Peers

Michael Kluge

IMMUN

ONCOL

PFM

CMN

Aldo Massimi United States

Andrew P. Voigt United States

Abhik Ray Chaudhury United States

Nora P. Dooley Canada

Mingzhe Zheng China

Candice C. Poon Canada

Pia S. Zeiner Germany

Scott H. Olejniczak United States

Martín Bonamino Brazil

Steffen Aulwurm Germany

Aldo Massimi United States

Michael Kluge

1.1k ×2.3

127 ×0.5

IMMUN

238 ×1.0

ONCOL

174 ×1.2

PFM

92 ×0.8

CMN

Citations per year, relative to Michael Kluge Michael Kluge (= 1×) peers Aldo Massimi

Countries citing papers authored by Michael Kluge

Since Specialization

Citations

This map shows the geographic impact of Michael Kluge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kluge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kluge more than expected).

Fields of papers citing papers by Michael Kluge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kluge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kluge. The network helps show where Michael Kluge may publish in the future.

Co-authorship network of co-authors of Michael Kluge

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kluge. A scholar is included among the top collaborators of Michael Kluge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kluge. Michael Kluge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Faust, H., et al.. (2024). Adult Neuropsychiatric Manifestation of Hartnup Disease With a Novel SLCA6A19 Variant. Neurology Genetics. 10(6). e200195–e200195. 1 indexed citations

Hennig, Thomas, Adam W. Whisnant, Christopher Jürges, et al.. (2023). HSV-1 Infection Induces a Downstream Shift of Promoter-Proximal Pausing for Host Genes. Journal of Virology. 97(5). e0038123–e0038123. 5 indexed citations

Hennig, Thomas, Katharina Reinisch, Andrea Milić, et al.. (2023). The HSV-1 ICP22 protein selectively impairs histone repositioning upon Pol II transcription downstream of genes. Nature Communications. 14(1). 4591–4591. 12 indexed citations

Friedl, Marie-Sophie, Michael Kluge, Thomas Hennig, et al.. (2022). HSV-1 and influenza infection induce linear and circular splicing of the long NEAT1 isoform. PLoS ONE. 17(10). e0276467–e0276467. 8 indexed citations

Mozos, Igor Ruiz de los, Michael Kluge, Benedict‐Tilman Berger, et al.. (2022). CDK11 regulates pre-mRNA splicing by phosphorylation of SF3B1. Nature. 609(7928). 829–834. 43 indexed citations

Mann, Carina C. de Oliveira, Stephan A. Müller, Michael Kluge, et al.. (2021). OAS1/RNase L executes RIG-I ligand–dependent tumor cell apoptosis. Science Immunology. 6(61). 29 indexed citations

Huang, Yong, Rut Tejero, Vivian K. Lee, et al.. (2021). Plexin-B2 facilitates glioblastoma infiltration by modulating cell biomechanics. Communications Biology. 4(1). 145–145. 22 indexed citations

Zhou, Xiang, Shalaka Wahane, Marie-Sophie Friedl, et al.. (2020). Microglia and macrophages promote corralling, wound compaction and recovery after spinal cord injury via Plexin-B2. Nature Neuroscience. 23(3). 337–350. 202 indexed citations

Metzger, Philipp, Sabrina V. Kirchleitner, Michael Kluge, et al.. (2019). Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer. Journal for ImmunoTherapy of Cancer. 7(1). 288–288. 25 indexed citations

10.

Kluge, Michael, Koen Bartholomeeusen, Jan Oppelt, et al.. (2019). CDK12 controls G1/S progression by regulating RNAPII processivity at core DNA replication genes. EMBO Reports. 20(9). e47592–e47592. 72 indexed citations

11.

Michaela, Rohrmoser, Michael Kluge, Gruber-Eber Anita, et al.. (2018). MIR sequences recruit zinc finger protein ZNF768 to expressed genes. Nucleic Acids Research. 47(2). 700–715. 15 indexed citations

12.

Legler, Karen, Charlotte A. E. Hauser, Jan‐Hen drik Egberts, et al.. (2018). The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cells. Cell Death and Disease. 9(5). 445–445. 33 indexed citations

13.

Kluge, Michael & Caroline C. Friedel. (2018). Watchdog – a workflow management system for the distributed analysis of large-scale experimental data. BMC Bioinformatics. 19(1). 97–97. 17 indexed citations

14.

Decker, Tim-Michael, Michael Kluge, Stefan Krebs, et al.. (2017). Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of small molecule inhibitor JQ1. Scientific Reports. 7(1). 1684–1684. 17 indexed citations

15.

Gieffers, Christian, Michael Kluge, Christian J. Merz, et al.. (2013). APG350 Induces Superior Clustering of TRAIL Receptors and Shows Therapeutic Antitumor Efficacy Independent of Cross-Linking via Fcγ Receptors. Molecular Cancer Therapeutics. 12(12). 2735–2747. 94 indexed citations

16.

Ruf, Peter, Michael Kluge, Michael Jäger, et al.. (2010). Pharmacokinetics, immunogenicity and bioactivity of the therapeutic antibody catumaxomab intraperitoneally administered to cancer patients. British Journal of Clinical Pharmacology. 69(6). 617–625. 65 indexed citations

17.

Kluge, Michael, et al.. (1996). Tumor Necrosis Factor Effects on Ascites Formation in an Experimental Tumor Model. Journal of Interferon & Cytokine Research. 16(5). 403–408. 8 indexed citations

18.

Vaupel, Peter, et al.. (1988). Microcirculatory and pH Alterations in Isotransplanted Rat and Xenotransplanted Human Tumors Associated with Hyperthermia. Recent results in cancer research. 109. 173–182. 8 indexed citations

19.

Vaupel, Peter, F. Kallinowski, & Michael Kluge. (1988). Pathophysiology of Tumors in Hyperthermia. Recent results in cancer research. 107. 65–75. 23 indexed citations

20.

Vaupel, Peter, et al.. (1988). Laser Doppler flowmetry in subepidermal tumours and in normal skin of rats during localized ultrasound hyperthermia. International Journal of Hyperthermia. 4(3). 307–321. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact